Eligibility Renal Cell Carcinoma NCT00862303

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
histologically proven renal cell carcinoma
Description

Histological determination of a renal cell carcinoma

Type de données

boolean

Alias
UMLS CUI [1,1]
C0449575
UMLS CUI [1,2]
C0007134
age: > 18
Description

Age

Type de données

boolean

Alias
UMLS CUI [1]
C0001779
who- ecog performance status 0-1
Description

ECOG perfomance status

Type de données

boolean

Alias
UMLS CUI [1]
C1520224
at least one measurable tumor lesions according to the recist criteria.
Description

Measurable tumor lesions according to the recist criteria

Type de données

boolean

Alias
UMLS CUI [1,1]
C1709926
UMLS CUI [1,2]
C1513041
life expectancy more than 3 months
Description

Life expectancy

Type de données

boolean

Alias
UMLS CUI [1]
C0023671
written informed consent
Description

Informed Consent

Type de données

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients with a history of any other neoplastic disease less than 5 years ago (excepting treated carcinomas in situ of the cervix and basal/squamous cell carcinomas of the skin).
Description

History of another neoplastic disease

Type de données

boolean

Alias
UMLS CUI [1]
C2735087
patients with metastatic disease in the central nervous system (cns).
Description

CNS metastasis

Type de données

boolean

Alias
UMLS CUI [1]
C0686377
patients with other significant illness including severe allergy, asthma, angina pectoris or congestive heart failure.
Description

Concomitant significant illness

Type de données

boolean

Alias
UMLS CUI [1]
C0243087
UMLS CUI [2]
C2945656
UMLS CUI [3]
C0004096
UMLS CUI [4]
C0002962
UMLS CUI [5]
C0018802
patients with acute or chronic infection including hiv.
Description

Acute or chronic infection

Type de données

boolean

Alias
UMLS CUI [1]
C3714514
UMLS CUI [2]
C0019682
patients who are pregnant or nursing.
Description

Pregnancy or breast feeding

Type de données

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
patients who have received antineoplastic therapy including chemotherapy or immunotherapy less than 4 weeks before beginning the trial.
Description

Prior antineoplastic therapy

Type de données

boolean

Alias
UMLS CUI [1]
C2346834
patients who receive corticosteroids or other immunosuppressive agents.
Description

Corticoid or immunosuppressive therapy

Type de données

boolean

Alias
UMLS CUI [1]
C0021079
UMLS CUI [2]
C0239126
patients with active autoimmune diseases such as lupus erythematosus, rheumatoid arthritis or thyroiditis.
Description

Concomitant autoimmune diseases

Type de données

boolean

Alias
UMLS CUI [1]
C0004364
UMLS CUI [2]
C0409974
UMLS CUI [3]
C0003873
UMLS CUI [4]
C0920350

Similar models

Eligibility Renal Cell Carcinoma NCT00862303

Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Histological determination of a renal cell carcinoma
Item
histologically proven renal cell carcinoma
boolean
C0449575 (UMLS CUI [1,1])
C0007134 (UMLS CUI [1,2])
Age
Item
age: > 18
boolean
C0001779 (UMLS CUI [1])
ECOG perfomance status
Item
who- ecog performance status 0-1
boolean
C1520224 (UMLS CUI [1])
Measurable tumor lesions according to the recist criteria
Item
at least one measurable tumor lesions according to the recist criteria.
boolean
C1709926 (UMLS CUI [1,1])
C1513041 (UMLS CUI [1,2])
Life expectancy
Item
life expectancy more than 3 months
boolean
C0023671 (UMLS CUI [1])
Informed Consent
Item
written informed consent
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
History of another neoplastic disease
Item
patients with a history of any other neoplastic disease less than 5 years ago (excepting treated carcinomas in situ of the cervix and basal/squamous cell carcinomas of the skin).
boolean
C2735087 (UMLS CUI [1])
CNS metastasis
Item
patients with metastatic disease in the central nervous system (cns).
boolean
C0686377 (UMLS CUI [1])
Concomitant significant illness
Item
patients with other significant illness including severe allergy, asthma, angina pectoris or congestive heart failure.
boolean
C0243087 (UMLS CUI [1])
C2945656 (UMLS CUI [2])
C0004096 (UMLS CUI [3])
C0002962 (UMLS CUI [4])
C0018802 (UMLS CUI [5])
Acute or chronic infection
Item
patients with acute or chronic infection including hiv.
boolean
C3714514 (UMLS CUI [1])
C0019682 (UMLS CUI [2])
Pregnancy or breast feeding
Item
patients who are pregnant or nursing.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Prior antineoplastic therapy
Item
patients who have received antineoplastic therapy including chemotherapy or immunotherapy less than 4 weeks before beginning the trial.
boolean
C2346834 (UMLS CUI [1])
Corticoid or immunosuppressive therapy
Item
patients who receive corticosteroids or other immunosuppressive agents.
boolean
C0021079 (UMLS CUI [1])
C0239126 (UMLS CUI [2])
Concomitant autoimmune diseases
Item
patients with active autoimmune diseases such as lupus erythematosus, rheumatoid arthritis or thyroiditis.
boolean
C0004364 (UMLS CUI [1])
C0409974 (UMLS CUI [2])
C0003873 (UMLS CUI [3])
C0920350 (UMLS CUI [4])